Lilly's obesity pill records modest second week as battle with Novo intensifies [Yahoo! Finance Canada]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Yahoo! Finance Canada
The ?pill, launched earlier this month as Foundayo, was prescribed 3,707 times in the U.S. in the week ?ended April 17, IQVIA data shared by Wall Street analysts showed, up from 1,390 in its debut week. Novo's Wegovy pill, launched in January, had clocked 18,410 prescriptions in its second week and 3,071 in the first four days after launch. Analysts would have liked ?to see Foundayo's second-week prescriptions ?closer to around 8,000 "to show that its relative spread to the oral Wegovy launch was at least being maintained," said Deutsche ?Bank analyst James Shin. RBC Capital Markets analyst Trung Huynh said while comparisons close to launch "should be considered immaterial, Foundayo's uptake this week is likely to be received negatively." Lilly shares ?were trading ?nearly 4% lower, while U.S.-listed Novo shares ?were about 6% higher. Foundayo prescriptions, totaling ?just 20% of what oral Wegovy achieved during its first full week, were "modest," noted Truist analyst Srikr
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Eli Lilly Slips as Obesity Prescriptions Lag [Yahoo! Finance]Yahoo! Finance
- 3 of Wall Street's Favorite Stocks with Questionable Fundamentals [Yahoo! Finance]Yahoo! Finance
- IQVIA (IQV) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IQV&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "buy".MarketBeat
- Lilly weight loss pill prescriptions said to near 1,400 in first week of launch [Seeking Alpha]Seeking Alpha
- IQVIA.ai Launch With NVIDIA Puts IQVIA's AI Valuation In Focus [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 2/5/26 - Beat
IQV
Sec Filings
- 4/23/26 - Form S-8
- 4/23/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- IQV's page on the SEC website